Techne grabs Bionostics for $104M

Techne ($TECH), a manufacturer of biological research products, has agreed to buy diagnostics outfit Bionostics for $104 million, a deal it expects to close early next year. Bionostics sells control solutions for the development of in vitro diagnostics, and Techne plans to roll the company's offerings into its R&D Systems business. More

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.